Chimin Health Management Co

Chimin Health Management Co Equity

The The Equity of Chimin Health Management Co (603222.SS) as of Nov 1, 2026 is 1.22 B CNY. In the previous year, The Equity was 1.48 B CNY — a change of -17.65% (lower).

Equity

1.22 BCNY

YoY

-17.65%

Last updated:

In 2025, Chimin Health Management Co's equity was 1.22 B CNY, a -17.65% increase from the 1.48 B CNY equity in the previous year.

The Chimin Health Management Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
809.72 M CNY
Jan 1, 2019
872.09 M CNY
Jan 1, 2020
864.75 M CNY
Jan 1, 2021
1.24 B CNY
Jan 1, 2022
1.71 B CNY
Jan 1, 2023
1.58 B CNY
Jan 1, 2024
1.48 B CNY
Jan 1, 2025
1.22 B CNY
The Chimin Health Management Co Equity history
YEAREquityYoY
1.22 BCNY-17.65%
1.48 BCNY-6.04%
1.58 BCNY-7.67%
1.71 BCNY+37.83%
1.24 BCNY+43.21%
864.75 MCNY-0.84%
872.09 MCNY+7.70%
809.72 MCNY+2.05%
793.44 MCNY+5.62%
751.24 MCNY+4.19%
721.03 MCNY+63.29%
441.55 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Chimin Health Management Co Stock analysis

What does Chimin Health Management Co do? Chimin Health Management Co., Ltd. generates revenue through the manufacturing and sale of pharmaceutical products, primarily focusing on Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery such as safety syringes, sterile syringes, and infusion sets. The company serves domestic and overseas markets, with its products distributed across these regions. Its core business involves producing medical devices and pharmaceutical packaging solutions for healthcare providers and distributors. The firm's product portfolio includes Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery products, which are sold to healthcare institutions and distributors within China and internationally. These products are essential for medical procedures requiring sterile fluid delivery and safe injection practices. Chimin Health Management's domestic market presence is complemented by its international distribution channels. Chimin Health Management Co., Ltd. operates with a workforce of 1,851 full-time employees, supporting its manufacturing and sales operations. The company's revenue streams are derived from the direct sale of its pharmaceutical and medical device products to healthcare providers and distributors, both within China and abroad. Its focus on Non Polyvinyl chloride (PVC) soft bag infusion products and related medical equipment positions it as a key supplier in the healthcare sector. Chimin Health Management Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Chimin Health Management Co's Equity

Chimin Health Management Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Chimin Health Management Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Chimin Health Management Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Chimin Health Management Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Chimin Health Management Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Chimin Health Management Co stock

The Equity of Chimin Health Management Co is 1.22 B CNY in 2025.

The Equity of Chimin Health Management Co changed from 1.48 B CNY to 1.22 B CNY, representing a -17.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Chimin Health Management Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Chimin Health Management Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Chimin Health Management Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Chimin Health Management Co